Figure 1
From: Frequency of Fabry disease in male and female haemodialysis patients in Spain

α-galactosidase A activity in control samples and in a haemodialysis population with both genders.
From: Frequency of Fabry disease in male and female haemodialysis patients in Spain
α-galactosidase A activity in control samples and in a haemodialysis population with both genders.